This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions
Hedda Wardemann, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction The Human B Cell Response to a Repetitive Malaria Parasite Protein
German Cancer Research Center (DKFZ)
Serge Muyldermans, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - Nanobodies: In Which Applications Will They Make a Difference?
Vrije Universiteit Brussel
Dennis Burton, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - Isolation of Potent SARS-CoV-2 Neutralizing Antibodies and Protection from Disease in a Small Animal Model
The Scripps Research Institute
Jeanette Leusen, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - Engineered IgA as Cancer Therapeutic
University Medical Center Utrecht
Jannie Borst, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - TNF Receptor Targeting in Cancer Immunotherapy
Leiden University Medical School
Sergio Quezada, PhD
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - Immunotherapeutic Approaches to Cancer
UCL Cancer Institute
Janice Reichert, Ph.D.
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A and Audience Interaction - Antibodies to Watch in a Pandemic
mAbs / The Antibody Society / Reichert Biotechnology Consulting LLC